by Katharina Buchholz Large volumes of vaccines are produced in developing countries, with the three largest Indian producers alone making up more than 40 percent of the global total of vaccine output in 2024. This is in stark contrast to the financial value of vaccines produced that year. Here, U. S. pharma companies Merck and Pfizer together The post Vaccine Production: Volume or Profits? appeared first on Pakistan & Gulf Economist.



